Albert David Limited operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Albert David Limited with three other
companies in this sector in India:
RPG Life Sciences Limited
sales of 3.30 billion Indian Rupees [US$45.76 million]
Amrutanjan Health Care Limited
(2.53 billion Indian Rupees [US$35.10 million]
of which 91%
was OTC Products), and
(3.58 billion Indian Rupees [US$49.61 million]
of which 48%
was Bulk Drugs).
Albert David Limited reported sales of 3.17 billion Indian Rupees (US$43.92 million)
March of 2019.
increase of 10.2%
versus 2018, when the company's sales were 2.87 billion Indian Rupees.
The sales level in 2019 was fairly close to the level five years ago: in 2014, Albert David Limited had sales
of 2.92 billion Indian Rupees.